Literature DB >> 17603424

Ischemic heart disease in women: an appropriate time to discriminate.

Jennifer A Tremmel1, Alan C Yeung.   

Abstract

Although cardiovascular mortality for men has been declining, the number of women dying from cardiovascular disease has slightly increased. Differences between women and men have been identified throughout the entire spectrum of ischemic heart disease, from risk factors to presentation and from diagnosis to treatment and outcomes. In the setting of an acute coronary syndrome or acute myocardial infarction, women are significantly more likely than men to report multiple non-chest pain symptoms, including dyspnea, nausea/vomiting, abdominal pain, back pain, neck pain, and jaw pain. Investigations into the pathophysiology of ischemic heart disease in women have broken away from the traditional thinking that coronary artery disease simply equals epicardial stenosis. In women, the new paradigm of coronary artery disease also focuses on diffuse atherosclerosis, endothelial dysfunction, and microvascular disease. Further research focusing on sex differences in cardiovascular disease is needed, but enough is currently known to offer a sex-based approach, which may ultimately lead to improved outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17603424

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  2 in total

1.  ST-segment depression during vasodilator stress is of minor clinical importance in women with normal myocardial perfusion imaging and low or intermediate risk of coronary artery disease.

Authors:  Dimitris J Apostolopoulos; Periklis Davlouros; Sotiria Alexiou; Nikolaos Patsouras; Trifon Spyridonidis; Pavlos J Vassilakos; Dimitrios Alexopoulos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-12-08       Impact factor: 9.236

2.  Patients with adenosine-induced ST-segment depressions and normal myocardial perfusion imaging: cardiac outcomes at 24 months.

Authors:  Jyoti Sharma; Christine Roncari; Kenneth N Giedd; John T Fox; Yumiko Kanei
Journal:  J Nucl Cardiol       Date:  2010-06-10       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.